These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2924383)

  • 1. Phase I trial of a new nitrosourea, CGP 6809, given every 2 weeks.
    Creaven PJ; Cowens JW; Huben R; Petrelli N; Karakousis C; Traynor D
    Cancer Chemother Pharmacol; 1989; 23(4):266-7. PubMed ID: 2924383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I clinical trial of ethyl 6-deoxy-3,5-di-O-methyl 6-(3 methyl-3-nitrosoureido)-alpha-D-glucofuranoside (CGP 6809).
    Creaven PJ; Madajewicz S; Cowens JW; Plager JE; Pendyala L; Mittelman A; Petrelli N; Karakousis C; Huben R; Takita H
    Cancer Chemother Pharmacol; 1987; 20(1):37-40. PubMed ID: 3304687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I clinical study of the new amino acid-linked nitrosourea, S 10036, administered on a weekly schedule.
    Khayat D; Lokiec F; Bizzari JP; Weil M; Meeus L; Sellami M; Rouesse J; Banzet P; Jacquillat C
    Cancer Res; 1987 Dec; 47(24 Pt 1):6782-5. PubMed ID: 3677107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I clinical evaluation of 1-(2-chloroethyl)-3-[2-(dimethylaminosulphonyl)ethyl]-1-nitrosou rea (TCNU).
    Vibe-Petersen J; Bork E; Møller H; Hansen HH
    Eur J Cancer Clin Oncol; 1987 Dec; 23(12):1837-43. PubMed ID: 3436347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phase I study of 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea (TA-077). Phase I Study Group].
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2425-33. PubMed ID: 3729497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of Perrimustine, a new cysteamine (2-chloroethyl) nitrosourea: an intrapatient escalation scheme.
    Kim-Triana B; Misset JL; Madelmont JC; Godenèche D; Musset M; Mathé G
    Anticancer Drugs; 1992 Jun; 3(3):225-31. PubMed ID: 1525402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study of TCNU, a novel nitrosourea.
    Smyth JF; Macpherson JS; Warrington PS; Kerr ME; Whelan JM; Cornbleet MA; Leonard RC
    Eur J Cancer Clin Oncol; 1987 Dec; 23(12):1845-9. PubMed ID: 3436348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phase II study on MCNU in patients with advanced or recurrent gastrointestinal cancer].
    Niimoto M; Yoshinaka K; Hattori T; Kobayashi S; Hosoma S; Ogawa Y; Iwamori S; Nagata N; Yamagata S; Nishimawari K
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1813-9. PubMed ID: 4037810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phase I study on oral administration of methyl-6-[[[(2-chloroethyl) nitrosoamino] carbonyl] amino]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
    Kanamaru A; Nagai K; Fujita S; Masaoka T; Takubo T; Kitani T; Taniguchi N; Horiuchi A; Tsubaki K; Kawagoe H; Hirata M; Yonezawa T; Tsubakio T; Yasunaga K; Okamoto Y; Fujitake H; Ohkubo A
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1831-7. PubMed ID: 6882006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I trial of cystemustine, a new cysteamine (2-chloroethyl) nitrosourea: an intrapatient escalation scheme.
    Mathé G; Misset JL; Triana BK; Godenèche D; Madelmont JC; Meyniel G
    Drugs Exp Clin Res; 1992; 18(4):155-8. PubMed ID: 1451646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A trial of 1-(2-chlorethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea in the treatment of patients with advanced gastro-intestinal cancer.
    Giles GR; Hall R; Brennan TG; Worthy TS
    Br J Surg; 1974 Dec; 61(12):950. PubMed ID: 4140746
    [No Abstract]   [Full Text] [Related]  

  • 12. [Phase II trial with cystemustine (60 mg/m2) in advanced or metastatic pretreated lung carcinoma].
    Rebattu P; Coudert B; Schneider M; Ouabdesselam R; Lentz M; Hanauske A; Chevallierdagger B; Fumoleau P; Chollet P
    Rev Pneumol Clin; 2000 Jun; 56(3):200-3. PubMed ID: 10880946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary results of phase I and II clinical trials of RFCNU, a new nitrosourea sugar derivative, in digestive tract tumours].
    Mathé G; Serrou B; Hayat M; De Vassal F; Misset JL; Schwarzenberg L; Machover D; Ribaud P; Belpomme D; Jasmin C; Musset M; Montero JL; Imbach JL
    Biomedicine; 1977 Nov; 27(8):294-7. PubMed ID: 339971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II study of methyl CCNU in the treatment of solid tumors and lymphomas: a Southwest Oncology Group study.
    Tranum BL; Haut A; Rivkin S; Weber E; Quagliana JM; Shaw M; Tucker WG; Smith FE; Samson M; Gottlieb J
    Cancer; 1975 Apr; 35(4):1148-53. PubMed ID: 1116106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phase II study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
    Tanaka I; Kobayashi T; Shirakawa S; Ikeda Y; Kobayashi M; Yamagata K; Ohta K; Ohno R; Yamada H; Yamada K
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):493-8. PubMed ID: 3859248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CGP 6809--a new nitrosoureido-sugar derivative with activity in human tumor xenografts.
    Fiebig HH; Widmer KH; Winterhalter BR; Löhr GW
    Cancer Chemother Pharmacol; 1989; 23(6):337-40. PubMed ID: 2713955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of tauromustine in disseminated malignant melanoma.
    Nolte H; Gjedde SB; Lindegaard-Madsen E; Bergh J; Blomquist E; Mouridsen HT
    Eur J Cancer Clin Oncol; 1989 Apr; 25(4):655-7. PubMed ID: 2714342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of cystemustine, a new nitrosourea, as treatment of high-grade brain tumors in adults.
    Roche H; Cure H; Adenis A; Fargeot P; Terret C; Lentz MA; Madelmont JC; Fumoleau P; Hanausk A; Chollet P
    J Neurooncol; 2000 Sep; 49(2):141-5. PubMed ID: 11206009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trail of PCNU in refractory advanced breast cancer.
    Kavanagh JJ; Yap HY; Blumenschein GR; Stewart D; Bodey GP
    Am J Clin Oncol; 1982 Jun; 5(3):249-51. PubMed ID: 7081144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phase II study of the water-soluble nitrosourea compound ACNU in advanced colorectal carcinomas].
    Fiebig HH; Wellens W; Peukert M; Henss H; Arnold H; Westerhausen M; Löhr GW
    Onkologie; 1984 Dec; 7(6):370-7. PubMed ID: 6396565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.